Huanrong Lan

1.6k total citations
62 papers, 1.1k citations indexed

About

Huanrong Lan is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Huanrong Lan has authored 62 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Oncology, 21 papers in Molecular Biology and 19 papers in Cancer Research. Recurrent topics in Huanrong Lan's work include Cancer Immunotherapy and Biomarkers (13 papers), Immunotherapy and Immune Responses (12 papers) and Colorectal Cancer Treatments and Studies (10 papers). Huanrong Lan is often cited by papers focused on Cancer Immunotherapy and Biomarkers (13 papers), Immunotherapy and Immune Responses (12 papers) and Colorectal Cancer Treatments and Studies (10 papers). Huanrong Lan collaborates with scholars based in China and Iran. Huanrong Lan's co-authors include Ketao Jin, Yuyao Liu, Xiaozhou Mou, Lisong Teng, Liming Huang, Xiaoyi Chen, Shibing Wang, Zhonghai Guan, Jinlong Liu and Kuifeng He and has published in prestigious journals such as PLoS ONE, Frontiers in Immunology and Experimental Cell Research.

In The Last Decade

Huanrong Lan

61 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huanrong Lan China 22 474 448 254 187 174 62 1.1k
Muxing Kang China 19 579 1.2× 328 0.7× 272 1.1× 126 0.7× 154 0.9× 33 1.1k
Yan Fan China 20 695 1.5× 453 1.0× 304 1.2× 353 1.9× 131 0.8× 67 1.5k
Thanh H. Dellinger United States 22 542 1.1× 424 0.9× 233 0.9× 152 0.8× 96 0.6× 77 1.3k
Tomasz Cichoń Poland 19 698 1.5× 378 0.8× 221 0.9× 348 1.9× 209 1.2× 58 1.4k
Peng Gong China 21 467 1.0× 399 0.9× 216 0.9× 133 0.7× 158 0.9× 68 1.2k
Haiping Jiang China 18 562 1.2× 385 0.9× 226 0.9× 191 1.0× 176 1.0× 45 1.2k
Ryszard Smolarczyk Poland 18 647 1.4× 373 0.8× 214 0.8× 340 1.8× 198 1.1× 48 1.4k
Yi Jer Tan China 13 694 1.5× 373 0.8× 260 1.0× 190 1.0× 117 0.7× 24 1.4k
Naoyo Nishida Japan 12 837 1.8× 401 0.9× 366 1.4× 150 0.8× 151 0.9× 27 1.5k
Guangyu Yao China 20 638 1.3× 359 0.8× 294 1.2× 226 1.2× 346 2.0× 45 1.4k

Countries citing papers authored by Huanrong Lan

Since Specialization
Citations

This map shows the geographic impact of Huanrong Lan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huanrong Lan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huanrong Lan more than expected).

Fields of papers citing papers by Huanrong Lan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huanrong Lan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huanrong Lan. The network helps show where Huanrong Lan may publish in the future.

Co-authorship network of co-authors of Huanrong Lan

This figure shows the co-authorship network connecting the top 25 collaborators of Huanrong Lan. A scholar is included among the top collaborators of Huanrong Lan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huanrong Lan. Huanrong Lan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Jin, Ketao, et al.. (2024). Exosomes in cancer diagnosis based on the Latest Evidence: Where are We?. International Immunopharmacology. 142(Pt A). 113133–113133. 2 indexed citations
3.
Wang, Jiayi, Huanrong Lan, Xiaowei Mao, & Yefeng Chen. (2024). Pituitary-adrenal axis dysfunction induced by tislelizumab immunotherapy for non-small cell lung cancer: a case series and literature review. BMC Pulmonary Medicine. 24(1). 327–327. 2 indexed citations
4.
Bao, Huan, Yun Chen, You-Ni Zhang, Huanrong Lan, & Ketao Jin. (2024). Exosomes-based immunotherapy for cancer: Effective components in the naïve and engineered forms. International Immunopharmacology. 139. 112656–112656. 1 indexed citations
5.
Lan, Huanrong, et al.. (2023). Can immunotherapy reinforce chemotherapy efficacy? a new perspective on colorectal cancer treatment. Frontiers in Immunology. 14. 1237764–1237764. 8 indexed citations
6.
7.
Lan, Huanrong, et al.. (2021). Role of immune regulatory cells in breast cancer: Foe or friend?. International Immunopharmacology. 96. 107627–107627. 19 indexed citations
8.
Lan, Huanrong, et al.. (2021). Personalized Immunotherapy in Colorectal Cancers: Where Do We Stand?. Frontiers in Oncology. 11. 769305–769305. 22 indexed citations
9.
Jin, Ketao, et al.. (2021). Monoclonal antibodies and chimeric antigen receptor (CAR) T cells in the treatment of colorectal cancer. Cancer Cell International. 21(1). 83–83. 28 indexed citations
10.
Lan, Huanrong, Yuyao Liu, Jinlong Liu, et al.. (2021). Tumor-Associated Macrophages Promote Oxaliplatin Resistance via METTL3-Mediated m6A of TRAF5 and Necroptosis in Colorectal Cancer. Molecular Pharmaceutics. 18(3). 1026–1037. 81 indexed citations
11.
Jin, Ketao, Xiaoyi Chen, Huanrong Lan, et al.. (2019). Current progress in the clinical use of circulating tumor cells as prognostic biomarkers. Cancer Cytopathology. 127(12). 739–749. 26 indexed citations
12.
Lan, Huanrong, et al.. (2017). Personalized and Dynamic Therapy for Breast Cancer: A Preclinical Perspective. 22(1). 22–22. 1 indexed citations
13.
Jin, Ketao, et al.. (2016). Totally laparoscopic D2 radical distal gastrectomy using Billroth II anastomosis: A case report. Oncology Letters. 11(3). 1855–1858. 2 indexed citations
14.
Shen, Yanping, Fang Zhang, Huanrong Lan, et al.. (2015). FRZB up-regulation is correlated with hepatic metastasis and poor prognosis in colon carcinoma patients with hepatic metastasis.. PubMed. 8(4). 4083–90. 7 indexed citations
15.
Huang, Dongsheng, Huanrong Lan, Fanlong Liu, et al.. (2015). Anti-angiogenesis or pro-angiogenesis for cancer treatment: focus on drug distribution.. PubMed. 8(6). 8369–76. 45 indexed citations
16.
Lan, Huanrong, Ketao Jin, Bojian Xie, et al.. (2012). Heterogeneity between primary colon carcinoma and paired lymphatic and hepatic metastases. Molecular Medicine Reports. 6(5). 1057–1068. 8 indexed citations
17.
Lan, Huanrong, Lingzhi Zheng, Ketao Jin, & Lisong Teng. (2012). Antitumor effect of FP3 in a breast cancer xenograft model. Experimental and Therapeutic Medicine. 5(1). 85–88. 2 indexed citations
18.
Jin, Ketao, Huanrong Lan, Zhenzhen Xu, et al.. (2012). Antitumor effect of FP3 in a patient-derived tumor tissue xenograft model of gastric carcinoma through an antiangiogenic mechanism. Oncology Letters. 3(5). 1052–1058. 8 indexed citations
19.
Jin, Ketao, et al.. (2012). FP3: A Novel VEGF Blocker with Anti-Angiogenic and Anti-Tumor Effects. Hepatogastroenterology. 59(120). 2543–7. 3 indexed citations
20.
Jin, Ketao, Guangliang Li, Binbin Cui, et al.. (2011). Assessment of a Novel VEGF Targeted Agent Using Patient-Derived Tumor Tissue Xenograft Models of Colon Carcinoma with Lymphatic and Hepatic Metastases. PLoS ONE. 6(12). e28384–e28384. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Muxing Kang Breakdown of academic impact, for papers by Yan Fan Breakdown of academic impact, for papers by Thanh H. Dellinger Breakdown of academic impact, for papers by Tomasz Cichoń Breakdown of academic impact, for papers by Peng Gong Breakdown of academic impact, for papers by Haiping Jiang Breakdown of academic impact, for papers by Ryszard Smolarczyk Breakdown of academic impact, for papers by Yi Jer Tan Breakdown of academic impact, for papers by Naoyo Nishida Breakdown of academic impact, for papers by Guangyu Yao
Rankless by CCL
2026